DE60029457D1 - Verfahren zur herstellung von feinkörnigen medizinischen substanzen - Google Patents

Verfahren zur herstellung von feinkörnigen medizinischen substanzen

Info

Publication number
DE60029457D1
DE60029457D1 DE60029457T DE60029457T DE60029457D1 DE 60029457 D1 DE60029457 D1 DE 60029457D1 DE 60029457 T DE60029457 T DE 60029457T DE 60029457 T DE60029457 T DE 60029457T DE 60029457 D1 DE60029457 D1 DE 60029457D1
Authority
DE
Germany
Prior art keywords
medicament
streams
fine
solvent
stream
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60029457T
Other languages
English (en)
Other versions
DE60029457T2 (de
Inventor
Dominique Begon
Pfefer Guillaume
Michael Kohl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis UK Holdings Ltd
Original Assignee
Aventis Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10859471&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60029457(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Ltd filed Critical Aventis Pharma Ltd
Publication of DE60029457D1 publication Critical patent/DE60029457D1/de
Application granted granted Critical
Publication of DE60029457T2 publication Critical patent/DE60029457T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/0018—Evaporation of components of the mixture to be separated
    • B01D9/0027—Evaporation of components of the mixture to be separated by means of conveying fluid, e.g. spray-crystallisation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F25/20—Jet mixers, i.e. mixers using high-speed fluid streams
    • B01F25/23—Mixing by intersecting jets
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F2025/91—Direction of flow or arrangement of feed and discharge openings
    • B01F2025/916—Turbulent flow, i.e. every point of the flow moves in a random direction and intermixes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F2101/00—Mixing characterised by the nature of the mixed materials or by the application field
    • B01F2101/22—Mixing of ingredients for pharmaceutical or medical compositions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/40—Mixing liquids with liquids; Emulsifying
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/30—Micromixers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Prostheses (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Materials For Medical Uses (AREA)
DE60029457T 1999-08-19 2000-08-18 Verfahren zur herstellung von feinkörnigen medizinischen substanzen Expired - Lifetime DE60029457T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9919693.3A GB9919693D0 (en) 1999-08-19 1999-08-19 Process
GB9919693 1999-08-19
PCT/GB2000/003178 WO2001014036A1 (en) 1999-08-19 2000-08-18 Process for producing fine medicinal substances

Publications (2)

Publication Number Publication Date
DE60029457D1 true DE60029457D1 (de) 2006-08-31
DE60029457T2 DE60029457T2 (de) 2007-07-19

Family

ID=10859471

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60029457T Expired - Lifetime DE60029457T2 (de) 1999-08-19 2000-08-18 Verfahren zur herstellung von feinkörnigen medizinischen substanzen

Country Status (14)

Country Link
US (2) US20030049321A1 (de)
EP (1) EP1214129B1 (de)
JP (1) JP4870300B2 (de)
AT (1) ATE333312T1 (de)
AU (1) AU781834B2 (de)
CA (1) CA2376269A1 (de)
DE (1) DE60029457T2 (de)
DK (1) DK1214129T3 (de)
ES (1) ES2269167T3 (de)
GB (1) GB9919693D0 (de)
HK (1) HK1046873A1 (de)
IL (2) IL148140A0 (de)
PT (1) PT1214129E (de)
WO (1) WO2001014036A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10119718A1 (de) * 2001-04-21 2002-10-31 Boehringer Ingelheim Pharma Verfahren zur kontinuierlichen Herstellung inhalierfähiger Arzneistoffe, Vorrichtung zur Durchführung des Verfahrens und nach diesem Verfahren hergestellter Arzneistoff
SG126676A1 (en) * 2001-05-09 2007-01-30 Nanomaterials Tech Pte Ltd Process for the controlled production of organic particles
DE10124952A1 (de) * 2001-05-21 2002-12-12 Bayer Ag Verfahren zur Herstellung von Nanodispersionen
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
WO2003032951A1 (en) * 2001-08-29 2003-04-24 Dow Global Technologies Inc. A process for preparing crystalline drug particles by means of precipitation
DE60210794T2 (de) * 2001-10-17 2007-05-10 E.I. Dupont De Nemours And Co., Wilmington Rotor-stator apparat und verfahren zur bildung von partikeln
DE10214031A1 (de) * 2002-03-27 2004-02-19 Pharmatech Gmbh Verfahren zur Herstellung und Anwendung von Mikro- und Nanoteilchen durch aufbauende Mikronisation
JP5172075B2 (ja) * 2002-10-17 2013-03-27 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 吸入可能な薬物の粉末を製造するための方法及びリアクター
GB0300339D0 (en) * 2003-01-08 2003-02-05 Bradford Particle Design Ltd Particle formation
EP2165745A1 (de) 2003-03-04 2010-03-24 Five Star Technologies, Inc. Hydrodynamische Kavitationskristallisierungsvorrichtung
JP2008533055A (ja) * 2005-03-18 2008-08-21 ナノマテリアルズ テクノロジー ピーティーイー リミテッド 吸入剤
JP5243247B2 (ja) * 2005-07-28 2013-07-24 アイエスピー インヴェストメンツ インコーポレイテッド スプレー乾燥された粉体及び粒状化された材料の特性の改良方法、並びにそれによって製造した製品
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
FR2897267A1 (fr) * 2006-02-16 2007-08-17 Flamel Technologies Sa Formes pharmaceutiques multimicroparticulaires pour administration per os
US20080085315A1 (en) * 2006-10-10 2008-04-10 John Alfred Doney Amorphous ezetimibe and the production thereof
WO2008076780A2 (en) * 2006-12-14 2008-06-26 Isp Investments Inc. Amorphous valsartan and the production thereof
US8613946B2 (en) * 2006-12-21 2013-12-24 Isp Investment Inc. Carotenoids of enhanced bioavailability
US20080181961A1 (en) * 2007-01-26 2008-07-31 Isp Investments, Inc. Amorphous oxcarbazepine and the production thereof
EP2125938A2 (de) * 2007-01-26 2009-12-02 Isp Investments Inc. Verfahren zur herstellung einer formulierung für sprühgetrocknete produkte
GB0705159D0 (en) 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals
EP2229233B1 (de) * 2007-12-07 2019-10-09 XSpray Pharma AB (publ) Verfahren zur partikelherstellung
DE102008037025C5 (de) * 2008-08-08 2016-07-07 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform
ES2359708B1 (es) * 2009-11-16 2012-03-30 Ferrer Internacional S.A. Procedimiento de preparación de la (11beta,16alfa)-9-fluoro-11-hidroxi-16,17-[1-metil-etilidenebis(oxi)]-21-[1-oxo-[4-(nitrooximetil)benzoxi]]preña-1,4-dien-3,20-diona.
DE102012221219B4 (de) * 2012-11-20 2014-05-28 Jesalis Pharma Gmbh Verfahren zur Vergrößerung der Partikelgröße kristalliner Wirkstoff-Mikropartikel
CA2897670C (en) * 2013-01-07 2021-04-06 Aciex Therapeutics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
GB201402556D0 (en) 2014-02-13 2014-04-02 Crystec Ltd Improvements relating to inhalable particles
EP4393473A1 (de) * 2022-12-30 2024-07-03 Yung Shin Pharmaceutical Ind. Co., Ltd. Herstellungsverfahren für medikamente

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US741756A (en) * 1903-03-02 1903-10-20 Werner P Arntz Journal-bearing.
US2334812A (en) * 1940-02-23 1943-11-23 Du Pont Process for the preparation of organic pigments
GB741756A (en) * 1953-02-24 1955-12-14 Secr Defence Brit Method for producing fine crystals of controlled particle size
US3299001A (en) * 1964-07-27 1967-01-17 Gen Dynamics Corp Isolation and purification of phosphonitrilic chloride adducts
US3622496A (en) * 1969-12-04 1971-11-23 Exxon Research Engineering Co Low-pour dewaxing process utilizing dual solvents
US3897779A (en) * 1973-06-27 1975-08-05 American Cyanamid Co Triamcinolone acetonide inhalation therapy
GB2121203B (en) * 1982-04-06 1985-10-16 Canon Kk Making toner particles
US4567912A (en) * 1984-07-30 1986-02-04 Acheson Industries, Inc. Multiple spray nozzles
US4767074A (en) * 1984-09-17 1988-08-30 Bower Glenister B Dispensing holder
US4663433A (en) * 1985-12-23 1987-05-05 General Electric Company Separation of cyclic oligomeric carbonate from high molecular weight polycarbonate
JPS62289257A (ja) * 1986-06-09 1987-12-16 Ikeuchi:Kk 超微霧噴射ノズル
US4915302A (en) * 1988-03-30 1990-04-10 Kraus Robert A Device for making artificial snow
US4952224A (en) * 1989-04-17 1990-08-28 Canadian Oxygen Limited Method and apparatus for cryogenic crystallization of fats
US5011293A (en) * 1989-10-12 1991-04-30 The United States Of America As Represented By The Secretary Of The Army Emulsifier mixing cell
IE67187B1 (en) * 1990-06-15 1996-03-06 Merck & Co Inc A crystallization method to improve crystal structure and size
US5074671A (en) * 1990-11-13 1991-12-24 Dew Engineering And Development Limited Mixing apparatus
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
ES2034891B1 (es) * 1991-08-08 1993-12-16 Cusi Lab Procedimiento de elaboracion en continuo de sistemas coloidales dispersos, en forma de nanocapsulas o nanoparticulas.
CA2143116A1 (en) * 1992-10-06 1994-04-14 Richard Dauer Dual jet crystallizer apparatus
US5665331A (en) * 1995-01-10 1997-09-09 Nanosystems L.L.C. Co-microprecipitation of nanoparticulate pharmaceutical agents with crystal growth modifiers
US5716642A (en) * 1995-01-10 1998-02-10 Nano Systems L.L.C. Microprecipitation of nanoparticulate pharmaceutical agents using surface active material derived from similar pharmaceutical agents
SE9501384D0 (sv) * 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
GB9905512D0 (en) * 1999-03-10 1999-05-05 Smithkline Beecham Plc Process

Also Published As

Publication number Publication date
US20050214228A1 (en) 2005-09-29
ATE333312T1 (de) 2006-08-15
IL148140A0 (en) 2002-09-12
IL148140A (en) 2006-04-10
WO2001014036A1 (en) 2001-03-01
AU6461500A (en) 2001-03-19
GB9919693D0 (en) 1999-10-20
ES2269167T3 (es) 2007-04-01
DK1214129T3 (da) 2006-09-25
EP1214129B1 (de) 2006-07-19
US20030049321A1 (en) 2003-03-13
PT1214129E (pt) 2006-10-31
CA2376269A1 (en) 2001-03-01
AU781834B2 (en) 2005-06-16
EP1214129A1 (de) 2002-06-19
JP2003527323A (ja) 2003-09-16
DE60029457T2 (de) 2007-07-19
HK1046873A1 (en) 2003-01-30
JP4870300B2 (ja) 2012-02-08

Similar Documents

Publication Publication Date Title
DE60029457D1 (de) Verfahren zur herstellung von feinkörnigen medizinischen substanzen
ATE381963T1 (de) Verfahren zur herstellung von gereinigten partikeln
HUP0203278A2 (hu) Új berendezés és eljárás kristályos részecskék előállítására
DE60201127D1 (de) Apparat und methode zur bildung von mikro- und submikropartikeln
DE69905460D1 (de) Verfahren und vorrichtung zur herstellung von partikeln
DE69629949D1 (de) Aktivierte verbindungen und verfahren zur herstellung und reiningung
ATE336231T1 (de) Verfahren zur herstellung kristalliner arzneimittelteilchen durch ausfällung
DE59309043D1 (de) Verfahren zur Herstellung von Pseudolatices und Mikro- oder Nanopartikeln und diese enthaltenden pharmazeutischen Präparaten
DE3886297D1 (de) Verfahren zur Herstellung von hochreinem Sauerstoffgas aus Luft.
ATE264931T1 (de) Vorrichtung und verfahren zum spinnen von materialien
DE69531957D1 (de) Granulat-präparate mit kontinuierlicher freisetzung und verfahren zur herstellung
ATE226563T1 (de) Aufbereitung von flugaschen durch ausbrennen von kohlenstoff in einem trockenen sprudel-wirbelbett
ATE471203T1 (de) Verfahren und vorrichtung zur grösssenabhängigen trennung von mikro- und nanopartikeln
IL207348A0 (en) Circular dna molecules, processes for their preparation, pharmaceutical compositions comprising them, and use thereof in the manufacture of medicinal products for producing recombinant proteins in vivo
DE69835230D1 (de) Verfahren zur herstellung von nordamerikanischen ginseng fraktionen, enthaltende produkte, und verwendung als immunmodulatoren
ATE172695T1 (de) Verfahren zur herstellung von pulvern und suspensionen von amorphen siliziumdioxidmikrokugeln
DE69806020D1 (de) Verfahren und apparat zur herstellung von vesikeln
DE50007511D1 (de) Verfahren zur kontinuierlichen herstellung von gefälltem calciumcarbonat
EP0248362A3 (en) Process for the production of an active protein from a biologically inactive form
ATE123746T1 (de) Verfahren und vorrichtung zur anaeroben biologischen reinigung mit organischen inhaltsstoffen belasteten wässern.
DE58905238D1 (de) Verfahren und vorrichtung zur reinigung von rohgas aus einer feststoff-vergasung.
ATE551993T1 (de) Verfahren und reaktor zur herstellung von pulvern für inhalative medikamente
ATE224907T1 (de) Verfahren zur reinigung von roxithromycin
ATE107539T1 (de) Verfahren zur behandlung von gasen.
DE68928634D1 (de) Verfahren zur Herstellung von aktivierten Killer-Monozyten und Verfahren zur Überprüfung ihrer tumoriziden Aktivität

Legal Events

Date Code Title Description
8363 Opposition against the patent
8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC